Back
Novonesis (Novozymes A/S) Vs. Cadre Holdings, Inc. Industry Stock Comparison
Buy
66
NVZMF
Novonesis (Novozymes A/S)
Last Price:
$60.05
Seasonality Move:
5.81%
Buy
54
CDRE
Cadre Holdings, Inc.
Last Price:
$32.52
Seasonality Move:
-5.8%
Buy
66
Novonesis (Novozymes A/S) (NVZMF)
is a Buy
Is Novonesis (Novozymes A/S) a Buy, Sell or Hold?
-
The current Novonesis (Novozymes A/S) [NVZMF] share price is $60.05. The Score for NVZMF is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
NVZMF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Cadre Holdings, Inc. (CDRE)
is a Buy
Is Cadre Holdings, Inc. a Buy, Sell or Hold?
-
The current Cadre Holdings, Inc. [CDRE] share price is $32.51. The Score for CDRE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
CDRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVZMF Stock Price Chart
What is Novonesis (Novozymes A/S)'s stock price today?
-
The Novonesis (Novozymes A/S) share price today is $60.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVZMF is experiencing slight buying pressure.
CDRE Stock Price Chart
What is Cadre Holdings, Inc.'s stock price today?
-
The Cadre Holdings, Inc. share price today is $32.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CDRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVZMF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.39 | Buy |
| Relative Strength Index (14 RSI): | 58.45 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.64 - 58.74) | Buy |
| Bollinger Bands (100): | (57.32 - 63.94) | Sell |
CDRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.55 | Sell |
| Relative Strength Index (14 RSI): | 40.33 | Sell |
| Chaikin Money Flow: | 399512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.88 - 41.76) | Sell |
| Bollinger Bands (100): | (36.45 - 44.81) | Sell |
NVZMF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.16 | Buy |
| 20-day SMA: | 55.45 | Buy |
| 50-day SMA: | 58.54 | Buy |
| 200-day SMA: | 62.9 | Sell |
| 8-day EMA: | 54.87 | Buy |
| 20-day EMA: | 39.63 | Buy |
| 50-day EMA: | 21.45 | Buy |
| 200-day EMA: | 6.34 | Buy |
CDRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.18 | Buy |
| 20-day SMA: | 33.49 | Sell |
| 50-day SMA: | 38.93 | Sell |
| 200-day SMA: | 37.6 | Sell |
| 8-day EMA: | 31.62 | Buy |
| 20-day EMA: | 33.71 | Sell |
| 50-day EMA: | 37.25 | Sell |
| 200-day EMA: | 38.01 | Sell |
Novonesis (Novozymes A/S) Earnings Growth & NVZMF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cadre Holdings, Inc. Earnings Growth & CDRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.13 per share.
Novonesis (Novozymes A/S) Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cadre Holdings, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||